Sessions are scheduled in Singapore Time (SGT)

Displaying One Session

Time
12:45 - 14:15

Welcome and introduction

Redefining the HER2-positive breast cancer

Untangling complexities in hereditary breast cancer

Horizons in hormone receptor-positive breast cancer: What’s next after CDK4/6 inhibitors?

Panel discussion

Summary and closing